These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8877348)

  • 41. Maintenance therapies for reflux esophagitis.
    Grey MR
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569838
    [No Abstract]   [Full Text] [Related]  

  • 42. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experience with omeprazole in erosive oesophagitis.
    Robinson MG; Decktor DL
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():69-77. PubMed ID: 1679674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term results of conservative management of reflux esophagitis].
    Viani F; Dorta G
    Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omeprazole: therapy of choice in intellectually disabled children.
    Böhmer CJ; Niezen-de Boer RC; Klinkenberg-Knol EC; Meuwissen SG
    Arch Pediatr Adolesc Med; 1998 Nov; 152(11):1113-8. PubMed ID: 9811290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of treating reflux oesophagitis with omeprazole on quality of life.
    McDougall NI; Collins JS; McFarland RJ; Watson RG; Love AH
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):459-64. PubMed ID: 9855059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimum management of mild esophagitis in Japan.
    Sugano K
    J Gastroenterol; 1999 Aug; 34(4):540-1. PubMed ID: 10452692
    [No Abstract]   [Full Text] [Related]  

  • 49. Omeprazole for peptic ulcer disease in pregnancy.
    Brunner G; Meyer H; Athmann C
    Digestion; 1998; 59(6):651-4. PubMed ID: 9813388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fundic gland polyps: three other case reports suggesting a possible association with acid suppressing therapy.
    Van Vlierberghe H; De Vos M; De Cock G; Cuvelier C; Elewaut A
    Acta Gastroenterol Belg; 1997; 60(3):240-2. PubMed ID: 9396183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of refractory ulcerative oesophagitis with omeprazole.
    Dalzell AM; Searle JW; Patrick MK
    Arch Dis Child; 1992 May; 67(5):641-2. PubMed ID: 1599306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of omeprazole in reflux oesophagitis.
    Dent J; Hetzel DJ; MacKinnon MA; Reed WD; Narielvala FM
    Scand J Gastroenterol Suppl; 1989; 166():76-82; discussion 94. PubMed ID: 2690334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric polyps and nodules in children receiving long-term omeprazole therapy.
    Pashankar DS; Israel DM
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):658-62. PubMed ID: 12454582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of reflux oesophagitis with H2-receptor antagonists.
    Meuwissen SG; Klinkenberg-Knol EC
    Scand J Gastroenterol Suppl; 1988; 146():201-13. PubMed ID: 2906465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
    Bium AL
    Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastro-oesophageal reflux: clinical profiles and outcome.
    Lee WS; Beattie RM; Meadows N; Walker-Smith JA
    J Paediatr Child Health; 1999 Dec; 35(6):568-71. PubMed ID: 10634985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic potential of NSAIDs and omeprazole in the oesophagus.
    Morgan GP
    Scand J Gastroenterol; 1997 Jan; 32(1):95. PubMed ID: 9018774
    [No Abstract]   [Full Text] [Related]  

  • 59. Histological esophagitis: clinical and histological response to omeprazole in children.
    Strauss RS; Calenda KA; Dayal Y; Mobassaleh M
    Dig Dis Sci; 1999 Jan; 44(1):134-9. PubMed ID: 9952234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
    Ahmed W; Qureshi H; Alam SE; Zuberi SJ
    J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.